Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Liver Cirrhosis Network Cohort StudyChemically-Induced Disorders, Cirrhosis, Cryptogenic, Digestive System Diseases, Fibrosis, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, fatty liver disease, hepatitis, immune system disorder, intrahepatic cholestasis, liver disorder, metabolic dysfunction-associated steatotic liver disease, primary biliary cholangitis, substance-related disorderActive, not recruitingNot stated2026-01-13NCT05740358

17 results · Page 1 of 1

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Central Virginia Veterans Healthcare SystemRichmondUnited States1
Cleveland ClinicClevelandUnited States2
Columbia University Iriving School of MedicineNew YorkUnited States2
Duke Liver CenterDurhamUnited States2
Keck Medical Center of USCLos AngelesUnited States21
LAC + USC Medical CenterLos AngelesUnited States2
Mayo ClinicRochesterUnited States22
New York Presbyterian/Weill CornellNew YorkUnited States2
UCSF Medical CenterSan FranciscoUnited States26
UCSF/Zuckerberg San Francisco General Hospital and Trauma CenterSan FranciscoUnited States2
University of California San Diego NAFLD Research CenterLa JollaUnited States2
University of Miami Health SystemMiamiUnited States2
University of MichiganAnn ArborUnited States538
Virginia Commonwealth UniversityRichmondUnited States156